Aug
31
2021
On demand

Are you finishing strong in cell therapy manufacturing? Tackling your final fill and finish challenges with automation.


Dalip Sethi

Director of Scientific Affairs, Terumo BCT

Dalip Sethi, is the Director of Scientific Affairs, and currently serves as Scientific and Clinical Development Lead for the cell therapy technologies portfolio at Terumo BCT. Prior to that, Dalip was engaged in the development of technologies and methods for use in cell therapy applications. He has authored multiple scientific publications, and is co-inventor on several patents.

Annie Cunningham

Laboratory Scientist, Terumo BCT

Annie Cunningham, is a Laboratory Scientist at Terumo BCT, were she is leading projects on the quantum cell expansion system, and the FINIA fill and finish system. Annie spent most of her career in the biotechnology industry, before shifting focus into immunotherapy, and contributing to the development of the CAR T program. She continued her research into the human immune system at the University of Colorado.


SPEAKERS

Dalip Sethi
Manager, Senior Scientist at Terumo BCT
Dalip Sethi
Manager, Senior Scientist at Terumo BCT
Dalip currently serves as the scientific development lead for the Cell Therapy Technologies portfolio at Terumo BCT. He holds a doctorate degree and conducted post-doctoral studies at Thomas Jefferson University, School of Medicine. Prior to Terumo BCT, Dalip was engaged in the development of technologies & methods for use in autologous cell therapy applications. Throughout his career, Dalip has authored multiple scientific publications and is a co-inventor on several patents & patent applications.
Annie Cunningham
Cell Therapy Laboratory Scientist
Annie Cunningham
Cell Therapy Laboratory Scientist
Annie Cunningham, is a Laboratory Scientist at Terumo BCT, were she’s leading projects on the quantum cell expansion system, and the FINIA fill and finish system.Annie spent most of her career in the biotechnology industry, before shifting focus into immunotherapy, and contributing to the development of the CART program. And she’s continued her research into the human immune system at the University of Colorado.